What does the evidence say about L-Glutamine Gut Health Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for L-Glutamine Gut Health Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated. [Zhang Y (2026); evidence level 1] - Moreover, immunonutrition reduced the incidence of overall postoperative complications (RR 0.64, 95% CI 0.55, 0.75) and postoperative abdominal distension (RR 0.33, 95% CI 0.12, 0.89). [Zhang Y (2026); evidence level 1] - Conclusion Perioperative immunonutrition supplementation significantly shortened the time to first flatus and time to first defecation after colorectal cancer surgery. [Zhang Y (2026); evidence level 1] - Objective The effect of immunonutrition on postoperative gastrointestinal recovery in patients undergoing colorectal cancer surgery remains controversial. [Zhang Y (2026); evidence level 1] - High-protein diets have dual effects on metabolic dysfunction-associated steatotic liver disease, depending on protein source and amount. [Yin Hong-Yuan (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.